15 results found.

Venous Thrombosis Clinical Trial using Rivaroxaban (Xarelto, BAY59-7939); Standard of care

Bayer - Recruiting 6 years to 17 years.
- 30-day, Open-label, Active-controlled, Randomized Study of the Safety, Efficacy and the Pharmacokinetic and Pharmacodynamic Properties of Oral Rivaroxaban in Children With Various Manifestations of Venous Thrombosis.
Rivaroxaban (Xarelto, BAY59-7939); Standard of care

Deep Venous Thrombosis, or Pulmonary Embolism Clinical Trial using LMWH

Leiden University Medical Center - Recruiting 18 years or older.
- Pot-Cast: Thrombosis Prophylaxis During Plaster Cast Lower Leg Immobilisation: Determining the Balance Between Benefits and Risks.
LMWH

Deep Venous Thrombosis, or Pulmonary Embolism Clinical Trial using LMWH

Leiden University Medical Center - Recruiting 18 years or older.
- Pot-Kast: Thrombosis Prophylaxis After Knee Arthroscopy: Determining the Balance Between Benefits and Risks.
LMWH

Venous Thrombosis Clinical Trial using Rivaroxaban (Xarelto, BAY59-7939)

Bayer - Recruiting 18 years or older.
- Belgian Real Life Non-interventional Study (NIS) in Patients Treated With Xarelto® Following an Acute Deep Vein Thrombosis (DVT).
Rivaroxaban (Xarelto, BAY59-7939)

Deep Vein Thrombosis, or Venous Thrombosis Clinical Trial using Rivaroxaban (Xarelto, BAY59-7939); Standard of care

Bayer - Recruiting 18 years or older.
- Xareltor for Long-term and Initial Anticoagulation in Venous Thromboembolism (VTE).
Rivaroxaban (Xarelto, BAY59-7939); Standard of care

Deep Vein Thrombosis, Venous Thrombosis, Postphlebitic Syndrome, Clinical Trial using Recombinant tissue plasminogen activator (rt-PA)

Washington University School of Medicine - Recruiting 16 years to 75 years.
- Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis--The ATTRACT Trial.
Recombinant tissue plasminogen activator (rt-PA)

Venous Thrombosis Clinical Trial using Neuromuscular electrical stimulator; AV Impulse System Model 6000

National University of Ireland, Galway, Ireland - Recruiting 18 years to 65 years.
- A Comparison of the Effects of Neuromuscular Electrical Stimulation and Intermittent Pneumatic Compression on Lower Limb Haemodynamics.
Neuromuscular electrical stimulator; AV Impulse System Model 6000

Venous Thrombosis, or Pediatrics Clinical Trial using Rivaroxaban (Xarelto, BAY59-7939)

Bayer - Recruiting 6 Months to 18 years.
- Single-dose Pilot Study of Oral Rivaroxaban in Pediatric Subjects With Venous Thromboembolism.
Rivaroxaban (Xarelto, BAY59-7939)

Deep Vein Thrombosis Clinical Trial

Indiana University - Recruiting 1 Month to 12 years.
- Incidence of Venous Thromboembolism in Children Undergoing Elective Neurosurgical Procedures.

Deep Vein Thrombosis, or Pulmonary Embolism Clinical Trial using Rosuvastatin

Leiden University Medical Center - Recruiting 18 years or older.
- Prospective Randomized Controlled, Open Label, Clinical Trial to Study if Rosuvastatin Use Improves the Coagulation Profile in Patients With Venous Thrombosis.
Rosuvastatin

Medical Patient, or Thrombocytopenia Clinical Trial using Fondaparinux

G. d'Annunzio University - Recruiting 18 years or older.
- Thromboprophylaxis With Fondaparinux of Deep Vein Thrombosis and Pulmonary Embolism in the Acutely-ill Medical Inpatients With Thrombocytopenia.
Fondaparinux

Deep Venous Thrombosis Clinical Trial using Low-Molecular-Weight Heparin

University of Tennessee - Recruiting 18 years to 85 years.
- Low-Molecular-Weight Heparin for DVT Prophylaxis After Open Reduction and Internal Fixation of Ankle Fractures: A Randomized, Prospective Trial.
Low-Molecular-Weight Heparin

Venous Thrombosis, or Pulmonary Embolism Clinical Trial using Enoxaparin

Monash Medical Centre - Recruiting 18 years or older.
- Two Weeks of Low Molecular Weight Heparin for Distal Vein Thrombosis (TWISTER).
Enoxaparin

Deep Venous Thrombosis Clinical Trial using Phenprocoumon; Warfarin-Natrium

University Hospital, Bonn - Recruiting 18 years to 85 years.
- Safety and Efficacy of a D-Dimer-Guided Strategy for Extension of Secondary Prophylaxis of Venous Thromboembolism - a Prospective and Randomized Management Trial.
Phenprocoumon; Warfarin-Natrium

Venous Thrombosis, Pulmonary Embolism, or Atrial Fibrillation Clinical Trial using Warfarin

Hadassah Medical Organization - Recruiting 18 years or older.
- Warfarin Induction Regimen Based Upon CYP2C9, VKORC1 Factor VII Genotyping, PMR and INR Monitoring, as Compared to the Conventional Regimen: a Prospective Controlled Study.
Warfarin